Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.23 CAD -4.44% Market Closed
Market Cap: 88.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Total Receivables
CA$6.3m
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
20%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Total Receivables
CA$110.2k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Total Receivables
$10.7m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
60%
ESSA Pharma Inc
NASDAQ:EPIX
Total Receivables
$163k
CAGR 3-Years
-31%
CAGR 5-Years
-16%
CAGR 10-Years
5%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Total Receivables
$36.5m
CAGR 3-Years
55%
CAGR 5-Years
136%
CAGR 10-Years
80%
Spectral Medical Inc
TSX:EDT
Total Receivables
CA$337k
CAGR 3-Years
-16%
CAGR 5-Years
2%
CAGR 10-Years
-6%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
88.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Total Receivables?
Total Receivables
6.3m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Total Receivables amounts to 6.3m CAD.

What is Covalon Technologies Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
20%

Over the last year, the Total Receivables growth was 21%. The average annual Total Receivables growth rates for Covalon Technologies Ltd have been 3% over the past three years , -2% over the past five years , and 20% over the past ten years .

Back to Top